OneSTOP Telehealth Program Using the EMPOWER App for Weight and Metabolic Health Management in Adults with Obesity, Type 2 Diabetes, and MASLD

What this Trial Is About

Researchers are evaluating a care model that combines teleconsultations and the EMPOWER app to support weight loss and metabolic improvements in adults who are obese with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease MASLD. This study compares this telehealth-based model to the conventional face-to-face weight management program to see if it is at least as effective and whether it offers more convenience and better adherence to diet and exercise routines. The study involves two groups over 26 weeks. One group receives standard care with 4 physical doctor and 4 dietician visits following best-practice guidelines. They get personalized exercise and calorie-deficit diet plans aiming for at least 5% weight loss. The other group, called the OneSTOP program, has at least half of these visits as teleconsults and uses the EMPOWER app to track weight, blood pressure, glucose, food intake, and exercise. The app provides reminders, health information, and helps with more precise calorie counting paired with an activity tracker. Participants will attend scheduled visits, upload their health data via the app if in the intervention group, and keep food and exercise records. Doctors and dieticians will review progress and adjust plans as needed. The main outcome measured is weight loss at 26 weeks, with secondary outcomes including the percentage achieving at least 5% weight loss, improvements in blood sugar control, and MASLD. The total study duration per participant is 26 weeks, with regular monitoring and support throughout.

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities